Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2023 07:17 ET | Source: Vantage Market Research

Multiple Myeloma Market Size & Share to Surpass $33.1 Billion by 2030 | Vantage Market Research

WASHINGTON, June 05, 2023 (GLOBE NEWSWIRE) -- The Global Multiple Myeloma Market is valued at USD 21.6 Billion in 2022 and is projected to reach a value of USD 33.1 Billion by 2030 at a CAGR...
June 05, 2023 06:07 ET | Source: Vantage Market Research

Prenatal Genetic Testing Market Size & Share to Surpass $24.9 Billion by 2030 | Vantage Market Research

WASHINGTON, June 05, 2023 (GLOBE NEWSWIRE) -- The Global Prenatal Genetic Testing Market is valued at USD 9.5 Billion in 2022 and is projected to reach a value of USD 24.9 Billion by 2030 at a CAGR...
June 05, 2023 05:03 ET | Source: Research and Markets

Global Pet DNA Testing Market to 2030: Rising Consumer Genomics Drives Growth

Dublin, June 05, 2023 (GLOBE NEWSWIRE) -- The "Pet DNA Testing Market Size, Share & Trends Analysis Report By Test Type (Genetic Diseases, Health & Wellness), By Animal Type (Dogs, Cats), By...
June 05, 2023 02:02 ET | Source: Mr. Narco Meme Token

Mr. Narco: The Revolution of Memecoins Smuggled on the Ethereum Blockchain

Singapore, June 05, 2023 (GLOBE NEWSWIRE) -- On the Ethereum blockchain, smuggling has taken on a new, exciting, and completely legal meaning. The memecoin project, christened Mr. Narco, or $NARCO,...
June 05, 2023 01:45 ET | Source: Bernstein Liebhard LLP

ALLBIRDS, INC. (NASDAQ: BIRD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allbirds, Inc.

Did you lose money on investments in Allbirds? If so, please visit Allbirds, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your...
June 04, 2023 21:00 ET | Source: Bragar Eagel & Squire

ALLBIRDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Allbirds, Inc. and Encourages Investors to Contact the Firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
June 04, 2023 09:39 ET | Source: Janssen Pharmaceutica NV

New Long-Term Data from the CHRYSALIS Study Show Median Progression-Free Survival Not Reached After 33.6 Months of Follow Up with First-Line Use of RYBREVANT®▼ (amivantamab) and Lazertinib Combination Therapy in Patients with Treatment-Naïve EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Further analyses from the Phase 1/1b CHRYSALIS-2 study showed patients with osimertinib pre-treated EGFR-mutated lung cancer who have a MET positive biomarker had an overall response rate of 61...
June 03, 2023 09:00 ET | Source: Elicio Therapeutics

Elicio Therapeutics Announces Positive Interim Data from the Phase 1 Study of an Investigational Therapeutic Cancer Immunotherapy, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer at the ASCO Annual Meeting

ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndromeA high proportion of patients had tumor biomarker reduction (77%) with 32% having complete...
June 03, 2023 07:00 ET | Source: Immunocore Holdings Limited

Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO

Early on-treatment ctDNA reduction in stable disease patients treated with KIMMTRAK was associated with longer overall survival (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md, 3...
June 02, 2023 08:36 ET | Source: Delvens

Molecular Diagnostics Market Worth USD 18,542 million by 2030, at a CAGR of 10.2%, Technology, Product, Service, Test Type, Application, End User, Region, Demand Side Analysis, Key Players, Drivers, Trends: Latest Report by Delvens

Chicago, June 02, 2023 (GLOBE NEWSWIRE) -- The global market for molecular diagnostics is expected to reach USD 18,542 million by 2030 from USD 9,892 million in 2022, registering impressive...